| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.32 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-07 |